Nurse Practitioner, Family · Charleston, SC
NPI
1710645775
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
267 services
Medicare patients, 2024
133
Average age 72
Drug cost, 2024
$7.4M
1,135 prescriptions
Company payments, 2025
$151
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth D Weiland was code 99215 (office e&m - established), 98 times for 64 patients. In total Elizabeth D Weiland billed 267 services in 10 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 98 | 64 | $84.82 | $8,312 |
| 99214 Office E&M - Established | Facility | 73 | 49 | $55.80 | $4,074 |
| 38222 Other Organ Systems | Facility | 65 | 53 | $41.73 | $2,713 |
By year: 2022 $20K for 309 services; 2023 $16K for 339 services; 2024 $17K for 267 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth D Weiland prescribed most often to Medicare patients was Acyclovir, with 237 prescriptions and refills. In total Elizabeth D Weiland wrote 1,135 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 237 | 308 | 44 | $4,064 |
| Ciprofloxacin Hcl Generic | 53 | 59 | 16 | $381 |
| Hydroxyurea Generic | 49 | 89 | 14 | $1,266 |
| Idhifa Enasidenib Mesylate | 43 | 43 | Under 11 | $1.4M |
| Scemblix Asciminib Hydrochloride | 38 | 38 | Under 11 | $860K |
| Imatinib Mesylate Generic | 38 | 38 | Under 11 | $89K |
| Jakafi Ruxolitinib Phosphate | 37 | 37 | Under 11 | $432K |
| Gleevec Imatinib Mesylate | 34 | 34 | Under 11 | $219K |
| Allopurinol Generic | 34 | 44 | Under 11 | $173 |
| Tibsovo Ivosidenib | 32 | 32 | Under 11 | $937K |
| Iclusig Ponatinib Hcl | 31 | 31 | Under 11 | $590K |
| Inrebic Fedratinib Dihydrochloride | 30 | 30 | Under 11 | $538K |
| Ojjaara Momelotinib Dihydrochloride | 28 | 28 | Under 11 | $748K |
| Potassium Chloride Generic | 25 | 33 | 12 | $304 |
| Sprycel Dasatinib | 24 | 24 | Under 11 | $224K |
Brand drugs: - claims; generic drugs: 717 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth D Weiland $151 ($151 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.